Business
Galapagos Announces Nomination of Gino Santini to its Board of Directors
Subject to his election by shareholders, the Board intends to appoint Mr. Santini as Chair, succeeding Jérôme Contamine Mr. Santini will bring extensive corporate governance, business development and industry leadership experience to the Board Mechelen, Belgium; March 26, 2026, 21:02 CET — Galapagos NV (Euronext & NASDAQ: GLPG), today announced the proposed appointment of Gino Santini as a Non-Executive Independent Director, with the intention to appoint him as Chair of its Board of Directors, s
About this update from Lakefront Biotherapeutics
[{"type":"image","alt":"Galapagos NV","displaySize":"","headline":null,"caption":"Galapagos NV","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":55,"url":"https://media.zenfs.com/en/globenewswire.com/231a79f212c8051361274fdd509bada9"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/RyU4QdTQ6l1b6Tbe7NtgrA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTc3/https://media.zenfs.com/en/globenewswire.com/231a79f212c8051361274fdd509bada9","width":300,"height":55}},"lazy":false},{"type":"text","content":"Subject to his election by shareholders, the Board intends to appoint Mr. Santini as Chair, succeeding Jérôme Contamine ","length":119,"tagName":"p"},{"type":"text","content":"Mr. Santini will bring extensive corporate governance, business development and industry leadership experience to the Board","length":123,"tagName":"p"},{"type":"text","content":"Mechelen, Belgium; March 26, 2026, 21:02 CET — Galapagos NV (Euronext & NASDAQ: GLPG), today announced the proposed appointment of Gino Santini as a Non-Executive Independent Director, with the intention to appoint him as Chair of its Board of Directors, subject to shareholder approval at the Annual Shareholders’ Meeting (AGM) on April 28, 2026.","length":351,"tagName":"p"},{"type":"text","content":"If elected, Gino Santini will replace current Director and Chair Jérôme Contamine, whose mandate as a member of the Board of Directors ends immediately after the AGM on April 28, 2026.","length":184,"tagName":"p"},{"type":"text","content":"“We are delighted to propose Gino for election to our Board of Directors,” said Henry Gosebruch, CEO and Executive Director of Galapagos. “His extensive operational, strategic and business development expertise shaped by global leadership in our sector will be invaluable as we execute on our strategy to deliver meaningful patient impact and sustainable shareholder returns.”","length":376,"tagName":"p"},{"type":"text","content":"Gosebruch continued: “I would also like to sincerely thank Jérôme for his leadership throughout this transformative period for Galapagos. His guidance and steadfast support through the strategic review and implementation of the company’s reinvention have been instrumental in positioning Galapagos for its next phase of growth and value creation. He has been a great partner and provided valuable insights.”","length":407,"tagNam...